Life Sciences · Pharmaceuticals & Biotech
Voranox Helix
“From molecule to market, intelligently engineered.”
Helix is the intelligence platform for the discovery, development, and stewardship of medicines — engineered to the cadence and standard of regulated life science.
ICH-GCP
Regulated by design
GxP
Validated quality posture
Global
FDA, EMA, MHRA, PMDA, NMPA
Provenanced
Every claim, traceable
The Helix Doctrine
Drug development is a multi-decade act of patience, capital, and scientific discipline. Voranox Helix exists to compress the parts of that journey that should be compressed, and to safeguard the parts that should not. From target identification to pharmacovigilance, Helix is engineered to the cadence of regulated life science — and to the moral stakes of medicine.
Pillars
The architecture of Helix.
01
Discovery
Target identification, validation, and drug design intelligence — engineered for medicinal chemists, biologists, and computational discovery teams.
02
Clinical Development
Trial design, site selection, recruitment, and operations intelligence — calibrated to ICH-GCP and the realities of multi-region clinical execution.
03
Pharmacovigilance
Real-world signal detection, case processing, and regulatory reporting intelligence at global scale — engineered for safety teams and DSURs.
04
Regulatory & Market Access
Regulatory strategy, dossier intelligence, and HTA/payer evidence synthesis for global filings and market access programs.
Capabilities
Engineered to the language of pharmaceuticals & biotech.
01
Target discovery
02
Trial design intelligence
03
Pharmacovigilance
04
Regulatory strategy
In Practice
Where Helix earns its keep.
01
Target identification at literature scale
Continuous synthesis of biomedical literature, omics, and preclinical evidence — to surface the targets a translational team would otherwise take months to find.
02
Adaptive trial design
Trial design, site selection, and recruitment intelligence — calibrated to historical execution data and engineered for protocol amendments at scale.
03
Continuous pharmacovigilance
Global signal detection across spontaneous reports, literature, and real-world data — with case processing automation and regulator-ready output.
04
HTA and payer evidence
Synthesis of comparative effectiveness, budget impact, and patient evidence into the dossier the payer or HTA body actually needs.
Doctrine
The principles we will not compromise.
- 01
Medicine is sacred. The model serves it.
- 02
Patient safety is the floor, not a feature.
- 03
Every claim is traceable to its evidence.
- 04
Regulation is the standard, not the obstacle.
Engaged By
Built for the institutions that operate at this scale.
Top-20 Pharmaceutical Companies
Clinical-Stage Biotech
Contract Research Organizations
Regulatory Agencies
HTA & Payer Bodies
Patient Advocacy Organizations
Engage Voranox Helix